INDEPENDENT Age: 70 Director Since: 2022 Committees: Audit Committee Ms. Dilsaver previously served as President and Chief Executive Officer of Charles Schwab Investment Management, the mutual fund arm of The Charles Schwab Corporation, from 2004 to 2007. Prior to that, Ms. Dilsaver served in various leadership roles at The Charles Schwab Corporation for more than 16 years beginning in 1991, including as Executive Vice President and Senior Vice President, Asset Management Products and Services of Charles Schwab Investment Management. Ms. Dilsaver also serves as a director of Bailard Private Real Estate Fund, a private company, and as an advisory board member at Protiviti Inc. Ms. Dilsaver received her B.A. in Accounting from California State University-Hayward, School of Business and Economics and participated in the Stanford Graduate School of Business, Senior Executive Program. Ms. Dilsaver has extensive executive leadership experience through her former role as President and Chief Executive Officer of Charles Schwab Investment Management, as well as various senior executive leadership roles at the Charles Schwab Corporation spanning over 16 years. Ms. Dilsaver brings extensive background and knowledge across both the financial and healthcare industries, as well as significant experience serving on the boards of directors of various public companies, including serving as a director and chair of the audit committee of Ortho until May 2022. Other Current Public Company Directorships: Tempur Sealy International Inc. - Audit Committee (chair) and Nominating and Corporate Governance Committee Health Equity, Inc. Nominating and Corporate Governance Committee (chair) PACS Group - Nominating and Corporate Governance Committee (chair), Audit Committee and Compensation Committee Prior Public Company Directorships Within the Past 5 Years: Ortho until May 2022 Audit Committee (chair)